US$ 23.43
tirzepatide used for diabetes Peptide of the Week: Tirzepatide, a Game Changer Type 2 and Obesity Management B.C. limits sale of 2
Description
Treatment strategies: Maximum tolerated dose of weekly subcutaneous tirzepatide (10 or 15 mg) vs maximum tolerated dose of semaglutide (1.7 or 2.4 mg)

More medication than prescribed may have been drawn per injection
We focus on understanding your individual health needs, reviewing your medical history, and discussing your goals to determine whether Tirzepatide is the most suitable option for you

At the 5 mg weekly dose, participants lost an average of 16.0% of their body weight over 72 weeks

Severe gastrointestinal disease: I would avoid in this scenario (including gastroparesis)
